Tuesday, April 25, 2017

BRIEF-MediciNova says exploratory interim clinical outcomes data from clinical trial of MN-166 in ALS

* Says it announced exploratory interim clinical outcomes data from clinical trial of MN-166 (ibudilast) in ALS presented at the American Academy of Neurology (AAN) 69th Annual Meeting in Boston

by reutersCOMPANYNEWS via Endless Supplies .Biz - News
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)